Sodium Lauryl Sulfate
CAS 151-21-3
Sodium Lauryl Sulfate (CAS 151-21-3) is a Phase 3 pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 571.7410714285714 ug.mL-1 | 28 | - |
| - | Potency | 39695.86666666667 nM | 20 | - |
| - | EC50 | 0.05444444444444444 % | 9 | - |
| - | IC50 | 41560.0444 nM | 5 | - |
| - | MIC | 0.01 % | 4 | - |
| - | MIC | 437500 nM | 4 | - |
| - | AC50 | 20437.5 nM | 3 | - |
| - | Ki | 2000 nM | 1 | - |
| Bifunctional epoxide hydrolase 2 Enzyme |
IC50 | 5.26 | - | Homo sapiens |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| SODIUM LAURYL SULFATE | 9871 | SU | MTHSPL |
| Sodium Lauryl Sulfate | 9871 | SU | MTHSPL |
| Sodium lauryl sulfate | 9871 | SU | MTHSPL |
| sodium lauryl sulfate | 9871 | SU | MTHSPL |
| sodium lauryl sulfate | 9871 | SY | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Sodium Lauryl Sulfate used for in pharmaceutical contexts?
Sodium Lauryl Sulfate (CAS 151-21-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Sodium Lauryl Sulfate?
No adverse-event association or SIDER side-effect rows are rendered for Sodium Lauryl Sulfate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Sodium Lauryl Sulfate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for SODIUM LAURYL SULFATE with EU status "permitted".
What clinical phase is Sodium Lauryl Sulfate in?
Sodium Lauryl Sulfate is rendered with ChEMBL max phase 3.
What bioactivity targets are documented for Sodium Lauryl Sulfate?
Sodium Lauryl Sulfate has 9 bioactivity rows in this page query. Rendered target entries include Bifunctional epoxide hydrolase 2.